Skip to main content

Work in progress

An overview of the medicines optimisation work underway, and due to be considered for endorsement by AWMSG.

Please note, information summarised on this page is subject to change.

Title Remit

Consultation date

Publication date
(Estimated)
Hypnotics and Anxiolytics (2021 review - current version here) Updated guidance for health professionals regarding the minimisation of risk associated with the prescribing of benzodiazepines and Z-drugs for the management of insomnia and anxiety. Consultation completed

Summer 2021
(June - August 2021)

All Wales Advice on SGLT‑2 Inhibitors in Type 2 Diabetes and Cardiovascular Disease A summary of evidence around cardiovascular risk reduction regarding the use of SGLT-2 inhibitor medicines and specific considerations for appropriate prescribing within the Type 2 diabetes management pathway. Consultation completed Autumn 2021
(September - November 2021)
Tramadol Educational Resources (2021 review - current version here) Updated resource materials aimed at supporting the appropriate prescribing of tramadol in NHS Wales by providing key healthcare professionals with resource materials to review the prescribing of tramadol within the complex context of pain management. Consultation completed Autumn 2021
(September - November 2021)
All Wales Guidelines and Resources for the Management of Chronic Pain Guidelines and resources developed to provide evidence based, prudently-driven guidance for the pharmacological management of chronic pain in Wales. In addition, quick reference guides, patient information leaflets, audit resources and educational materials will also be developed. Consultation anticipated July - August 2021 Autumn 2021
(September - November 2021)
All Wales Adult Asthma Management and Prescribing Guidelines (2021 review - current version here) Guidelines developed with the aim to reduce variation in inhaler prescribing across NHS Wales. Consultation anticipated August 2021 Autumn 2021 (September - November 2021)
All Wales COPD Management and Prescribing Guidelines (2021 review - current version here) Guidelines developed with the aim to reduce variation in inhaler prescribing across NHS Wales. Consultation anticipated August 2021 Autumn 2021 (September - November 2021)
National Prescribing Indicators 2022-2023

Review and update of the National Prescribing Indicators (NPIs) for the financial year 2022-2023.

Information on the NPIs for 2021-2022 can be found here.

Consultation anticipated August 2021 Autumn 2021 (September - November 2021)
Primary Care Antimicrobial Guidelines (2021 review - current version here) Guidelines developed to provide comprehensive standardised guidance for the use of antimicrobials/treatment of infections in primary care across Wales. Consultation anticipated October - November 2021 Winter 2021-2022
(December 2021 - February 2022)
CEPP National Audit - focus on antibiotic prescribing (2021 review - current version here) A package of audits developed to promote antibiotic prescribing in accordance with the latest guidelines and to support clinicians in promoting quality improvement by reviewing antimicrobial prescribing within their teams. Consultation anticipated October - November 2021 Winter 2021-2022
(December 2021 - February 2022)